For the Inventor, By the Inventor

Enter assignee name

Lincoln, RI, United States of America

Cytotherapeutics, Inc.

Calculating rank

USPTO Granted Patents = 32

Forward Citations = 2,730

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Joseph P Hammang (16 out of 34 patents)

Frank T Gentile (15 out of 31 patents)

Shelley R Winn (14 out of 19 patents)

4. Patrick Aebischer (11 out of 47 patents)

5. Edward J Doherty (10 out of 24 patents)

6. Laura M Holland (9 out of 11 patents)

7. Molly S Shoichet (9 out of 29 patents)

8. Brian M Cain (8 out of 14 patents)

9. Malcolm Schinstine (8 out of 8 patents)

10. Dwaine F Emerich (6 out of 17 patents)

11. Mark D Lindner (5 out of 6 patents)

12. Edward E Baetge (5 out of 6 patents)

13. Orion D Hegre (4 out of 15 patents)

14. Melissa K Carpenter (3 out of 32 patents)

15. Keith E Dionne (3 out of 39 patents)

Core Competencies:

Neural Stem Cells

Gene Therapy

Bioartificial Organs

Analgesia

Cell Proliferation

Encapsulation

Biocompatible Devices

Nerve Guidance Channels

Ophthalmic Diseases

Biologically Active Delivery

PC12 Cell Transplants

Glucose Responsive Insulin

32 patents: Sort by Forward Citations

1. 6498018 - Cultures of human CNS neural stem cells (2002-12-24),

2. 6407204 - Use of conantokins for producing analgesia or for neuoprotection (2002-06-18),

3. 6103530 - Cultures of human CNS neural stem cells (2000-08-15),

4. 6054142 - Biocompatible devices with foam scaffolds (2000-04-25),

5. 6027721 - Device and method for encapsulated gene therapy (2000-02-22),

6. 5968829 - Human CNS neural stem cells (1999-10-19),

7. 5935849 - Methods and compositions of growth control for cells encapsulated within (1999-08-10),

8. 5908623 - Compositions and methods for the delivery of biologically active (1999-06-01),

9. 5904144 - Method for treating ophthalmic diseases (1999-05-18),

10. 5858747 - Control of cell growth in a bioartificial organ with extracellular (1999-01-12),

11. 5853717 - Methods and compositions of growth control for cells encapsulated within (1998-12-29),

12. 5853385 - Encapsulated PC12 cell transplants for treatment of Parkinson's disease (1998-12-29),

13. 5844077 - Use of conantokins for producing analgesia or for neuroprotection (1998-12-01),

14. 5843431 - Controlling proliferation of cells before and after encapsulation in a (1998-12-01),

15. 5840576 - Methods and compositions of growth control for cells encapsulated within (1998-11-24),

Company Overview

Cytotherapeutics, Inc. is a biotechnology company based in Lincoln, Rhode Island, specializing in the development of innovative cell-based therapies. The organization focuses on harnessing the potential of stem cells and other cellular technologies to create treatments for various medical conditions. With a commitment to advancing regenerative medicine, Cytotherapeutics aims to address unmet medical needs through its research and development efforts, contributing to the evolving landscape of therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

32 Patents

#1 in Lincoln, RI

#61 in Rhode Island

#10,628 in US

#20,746 in the World

Lincoln, RI, United States of America

Cytotherapeutics, Inc.

Forward Citations = 2,730

38 inventors:

Joseph P Hammang (16 out of 34 patents)

Frank T Gentile (15 out of 31 patents)

Shelley R Winn (14 out of 19 patents)

4. Patrick Aebischer (11 out of 47 patents)

5. Edward J Doherty (10 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytotherapeutics, Inc.. Retrieved from https://idiyas.com/company/cytotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…